{"schema_version":"secwatch.filing_event.v1","accession":"0001437749-24-036441","form_type":"8-K","ticker":"INBP","cik":"0001016504","company_name":"INTEGRATED BIOPHARMA INC","filed_at":"2024-12-02T23:59:59+00:00","discovered_at":"2026-05-14T18:03:07.385358+00:00","generated_at":"2026-05-29T10:51:37.776166+00:00","sec_items":["5.07","9.01"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.25,"calibrated_materiality_score":0.15,"confidence":"high","headline":"Integrated BioPharma elects two Class I directors, ratifies Marcum as auditor at 2024 annual meeting","bullets":["Elected Damon DeSantis as Class I director: 20,448,871 for, 142,036 withheld, 1,342,353 broker non-votes.","Elected Riva Sheppard as Class I director: 20,301,671 for, 289,236 withheld, 1,342,353 broker non-votes.","Ratified appointment of Marcum LLP as independent auditor for FY2025: 21,905,273 for, 9,287 against, 18,700 abstain.","Total shares voted: 21,933,260 of 30,099,610 entitled; quorum present."],"urls":{"canonical":"https://secwatch.observer/filing/0001437749-24-036441","json":"https://secwatch.observer/filing/0001437749-24-036441.json","markdown":"https://secwatch.observer/filing/0001437749-24-036441.md","text":"https://secwatch.observer/filing/0001437749-24-036441.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1016504/000143774924036441/0001437749-24-036441-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1016504/000143774924036441/inbp20241202_8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-29T10:51:37.776166+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}